Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Seiler

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|September 30, 2003
Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokinesPeter Seiler, Peter Aichele, Silke Bandermann, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infectionsHans H Locher, Peter Seiler, Xinhua Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2003
Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodiesLars Hangartner, Beatrice M Senn, Birgit Ledermann, et al.
The Journal of Pathology|March 19, 2005
Modified immunohistological staining allows detection of Ziehl-Neelsen-negative Mycobacterium tuberculosis organisms and their precise localization in human tissueTimo Ulrichs, Michael Lefmann, Maja Reich, et al.
Journal of Medicinal Chemistry|April 14, 2017
Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial AgentsPhilippe Panchaud, Thierry Bruyère, Anne-Catherine Blumstein, et al.
Journal of Medicinal Chemistry|May 16, 2024
Discovery and Structure-Activity Relationship of Cadazolid: A First-In-Class Quinoxolidinone Antibiotic for the Treatment of <i>Clostridioides difficile</i> InfectionGeorg Rueedi, Philippe Panchaud, Astrid Friedli, et al.
The Journal of Clinical Investigation|August 20, 2005
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysinLeander Grode, Peter Seiler, Sven Baumann, et al.
Journal of Medicinal Chemistry|April 14, 2017
Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative BacteriaJean-Philippe Surivet, Cornelia Zumbrunn, Thierry Bruyère, et al.
Journal of Medicinal Chemistry|December 6, 2019
Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous AdministrationPhilippe Panchaud, Jean-Philippe Surivet, Stefan Diethelm, et al.
Journal of Medicinal Chemistry|August 24, 2013
Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activityJean-Philippe Surivet, Cornelia Zumbrunn, Georg Rueedi, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|September 30, 2003
Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokinesPeter Seiler, Peter Aichele, Silke Bandermann, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infectionsHans H Locher, Peter Seiler, Xinhua Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2003
Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodiesLars Hangartner, Beatrice M Senn, Birgit Ledermann, et al.
The Journal of Pathology|March 19, 2005
Modified immunohistological staining allows detection of Ziehl-Neelsen-negative Mycobacterium tuberculosis organisms and their precise localization in human tissueTimo Ulrichs, Michael Lefmann, Maja Reich, et al.
Journal of Medicinal Chemistry|April 14, 2017
Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial AgentsPhilippe Panchaud, Thierry Bruyère, Anne-Catherine Blumstein, et al.
Journal of Medicinal Chemistry|May 16, 2024
Discovery and Structure-Activity Relationship of Cadazolid: A First-In-Class Quinoxolidinone Antibiotic for the Treatment of <i>Clostridioides difficile</i> InfectionGeorg Rueedi, Philippe Panchaud, Astrid Friedli, et al.
The Journal of Clinical Investigation|August 20, 2005
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysinLeander Grode, Peter Seiler, Sven Baumann, et al.
Journal of Medicinal Chemistry|April 14, 2017
Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative BacteriaJean-Philippe Surivet, Cornelia Zumbrunn, Thierry Bruyère, et al.
Journal of Medicinal Chemistry|December 6, 2019
Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous AdministrationPhilippe Panchaud, Jean-Philippe Surivet, Stefan Diethelm, et al.
Journal of Medicinal Chemistry|August 24, 2013
Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activityJean-Philippe Surivet, Cornelia Zumbrunn, Georg Rueedi, et al.
Pageof 3